Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Nov 02, 2022 11:44am
74 Views
Post# 35066495

RE:RE:RE:Meaning of rapid growth?

RE:RE:RE:Meaning of rapid growth?

Don't believe the co. spin that it chose to take a lower upfront. More likely Abbvie said take it or shove it.   

Pareto8020 wrote: Hopefully they can deliver on something b4 year end cause I don't want to see where the share price will be once tax loss selling kicks in full steam considering where the share price is now.

 I shouldn't be but I'm still surprised Howie and the board (which he controls if we are being realistic) thought let's take next to nothing for an upfront payment.  In what universe does that make sense for a small bio cap with a burn rate to skip out on some funding before royalty payments kick in?!  Completely bonkers.  Hence a Dec 30th AGM I guess.  You can't even make this stuff up and make it sound as crazy as it is in SBM's reality.

 

<< Previous
Bullboard Posts
Next >>